BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38040060)

  • 21. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
    Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
    Trifiletti DM; Grover S; Libby B; Showalter TN
    Brachytherapy; 2017; 16(3):547-551. PubMed ID: 28336252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High versus low-dose rate brachytherapy for cervical cancer.
    Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
    Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
    Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
    Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
    Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSA: Declining utilization of prostate brachytherapy.
    Andring L; Yoder A; Pezzi T; Tang C; Kumar R; Mahmood U; Walker GV
    Brachytherapy; 2022; 21(1):6-11. PubMed ID: 34420862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
    Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
    Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea.
    Kim YA; Yang MS; Park M; Choi MG; Kim SY; Kim YJ
    J Gynecol Oncol; 2021 Nov; 32(6):e85. PubMed ID: 34431256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose-rate intra-cavitary brachytherapy combined with external beam radiation therapy for under 40-year-old patients with invasive uterine cervical carcinoma: clinical outcomes in 118 Patients in a Japanese multi-institutional study, JASTRO.
    Yamashita H; Niibe Y; Toita T; Kazumoto T; Nishimura T; Kodaira T; Eto H; Kinoshita R; Tsujino K; Onishi H; Takemoto M; Hayakawa K
    Jpn J Clin Oncol; 2013 May; 43(5):547-52. PubMed ID: 23475536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.
    Modh A; Ghanem AI; Burmeister C; Rasool N; Elshaikh MA
    Brachytherapy; 2016; 15(5):554-61. PubMed ID: 27475480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
    Murofushi K; Yoshioka Y; Sumi M; Ishikawa H; Oguchi M; Sakurai H
    Int J Gynecol Cancer; 2020 Apr; 30(4):473-479. PubMed ID: 32165406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.
    Rajagopalan MS; Xu KM; Lin J; Hansen K; Sukumvanich P; Krivak TC; Kelley JL; Beriwal S
    Pract Radiat Oncol; 2015; 5(1):56-61. PubMed ID: 25413431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival.
    Moelle U; Mathewos A; Aynalem A; Wondemagegnehu T; Yonas B; Begoihn M; Addissie A; Unverzagt S; Jemal A; Thomssen C; Vordermark D; Kantelhardt EJ
    Oncologist; 2018 Sep; 23(9):1024-1032. PubMed ID: 29567823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.